Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome

Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome

MSCs products as well as their derived extracellular vesicles, are currently being explored as advanced biologics in cell-based therapies with high expectations for their clinical use in the next few years. In recent years, various strategies designed for improving the therapeutic potential of mesen...

Full description

Bibliographic Details
Main Authors: Maria Eugenia Fernández-Santos, Mariano Garcia-Arranz, Enrique J. Andreu, Ana Maria García-Hernández, Miriam López-Parra, Eva Villarón, Pilar Sepúlveda, Francisco Fernández-Avilés, Damian García-Olmo, Felipe Prosper, Fermin Sánchez-Guijo, Jose M. Moraleda, Agustin G. Zapata
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
MSCs
ATMPs
legal requirements
GMP manufacturing
extracellular vesicles
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.918565/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.918565/full

Similar Items